CoChat

Improved Prognosis and Low Failure Rate with Anticoagulation as First‐Line Therapy in Mesenteric Venous Thrombosis

Open access
Salim, S., Zarrouk, M., Elf, J., Gottsäter, A., Ekberg, O., Acosta, S. · 2018 · World Journal of Surgery
Cited by 24

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Background: Monotherapy with anticoagulation has been considered as first‐line therapy in patients with mesenteric venous thrombosis (MVT). The aim of this study was to evaluate outcome, prognostic factors, and failure rate of anticoagulation as monotherapy, and to identify when bowel resection was needed. Methods: Retrospective study of consecutive patients with MVT diagnosed between 2000 and 2015. Results: The overall incidence rate of MVT was 1.3/100,000 person‐years. Among 120 patients, seven died due to autopsy‐verified MVT without bowel resection and 15 underwent immediate bowel resection without prior anticoagulation therapy. The remaining 98 patients received anticoagulation monotherapy, whereof 83 (85%) were treated successfully. Fifteen patients failed on anticoagulation monotherapy, of whom seven underwent bowel resection and eight endovascular therapy. Endovascular therapy was followed by bowel resection in three patients. Two late bowel resections were performed due to intestinal stricture. The 30‐day mortality rate was 19.0% in the former (2000–2007) and 3.2% in the latter (2008–2015) part of the study period (p = 0.006). Age ≥75 years (OR 12.4, 95% CI [2.5–60.3]), management during the former as opposed to the latter time period (OR 8.4, 95% CI [1.3–54.7]), and renal insufficiency at admission (OR 8.0, 95% CI [1.2–51.6]) were independently associated with increased mortality in multivariable analysis. Conclusions: Short‐term prognosis in patients with MVT has improved. Contemporary data show that monotherapy with anticoagulation is an effective first choice in MVT patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00268-018-4667-x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 11

  1. 10.1007/s10140‐009‐0807‐9 · DOI
  2. 10.1093/eurheartj/ehr134 · DOI · Paper page
  3. 10.1002/bjs.6319 · DOI · Paper page
  4. 10.1007/s11605‐009‐1130‐1 · DOI · Paper page
  5. 10.1056/NEJMra1700365 · DOI · Paper page
  6. Hakoum MB, 2018, Anticoagulation for the initial treatment of venous thromboembolism in people with cancer, Cochrane Database Syst Rev, 1, 006649
  7. 10.1001/jamainternmed.2015.3184 · DOI · Paper page
  8. 10.1046/j.1365‐2796.1997.00178.x · DOI · Paper page
  9. 10.1186/s12872‐016‐0215‐5 · doi:10.1186/s12872-016-0215-5
  10. 10.1016/j.ejvs.2015.02.007 · DOI · Paper page
  11. 10.1053/gast.2001.21209 · DOI · Paper page

Cited by

See all 24

Metadata

Authors
Salim, S., Zarrouk, M., Elf, J., Gottsäter, A., Ekberg, O., & Acosta, S.
Venue
World Journal of Surgery
Publisher
Wiley
Published
2018-05-17
Volume
42
Issue
11
Pages
3803-3811
ISSN
  • 0364-2313 (ISSN-L)
  • 1432-2323
OpenAlex
W2804461771
Cited by
24
References
9
FWCI
1.65
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
Scandinavian Research Foundation for Venous Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improved Prognosis and Low Failure Rate with Anticoagulation as First‐Line Therapy in Mesenteric Venous Thrombosis. https://app.cochat.ai/papers/10.1007/s00268-018-4667-x
The paper
Salim, S., Zarrouk, M., Elf, J., Gottsäter, A., Ekberg, O., & Acosta, S. (2018). Improved Prognosis and Low Failure Rate with Anticoagulation as First‐Line Therapy in Mesenteric Venous Thrombosis. World Journal of Surgery. https://doi.org/10.1007/s00268-018-4667-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.